All of the statements are true about Brugada syndrome, EXCEPT:

The major clinical features of Brugada syndrome include, transient, or concealed ST segment elevation in V1 to V3 that typically can be provoked with the sodium channel-blocking drugs flecainide, and procainamide and a risk of polymorphic ventricular arrhythmias. Ref: Harrisons Principles of Internal Medicine, 18th Edition, Page 1898.